NPI: 1205882503 · LAS CRUCES, NM 88011 · General Acute Care Hospital · NPI assigned 05/26/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 05/26/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 320,008 | $13.80M |
| 2019 | 235,614 | $10.93M |
| 2020 | 187,670 | $8.99M |
| 2021 | 238,103 | $11.10M |
| 2022 | 290,141 | $13.71M |
| 2023 | 321,339 | $14.67M |
| 2024 | 298,234 | $13.47M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 149,727 | 141,120 | $13.76M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 71,361 | 68,942 | $10.68M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 49,011 | 46,312 | $9.64M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 11,732 | 11,240 | $4.99M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11,465 | 10,778 | $2.83M |
| 70450 | Computed tomography, head or brain; without contrast material | 10,240 | 9,765 | $2.25M |
| 80053 | Comprehensive metabolic panel | 109,035 | 95,201 | $1.95M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 18,111 | 17,758 | $1.76M |
| 87430 | 82,620 | 80,574 | $1.73M | |
| 87400 | 63,595 | 53,865 | $1.47M | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 48,890 | 47,489 | $1.41M |
| 71045 | Radiologic examination, chest; single view | 22,113 | 20,592 | $1.36M |
| G0378 | Hospital observation service, per hour | 3,440 | 3,190 | $1.26M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 18,738 | 15,919 | $1.18M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 19,233 | 18,784 | $1.18M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 19,868 | 5,738 | $1.03M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3,001 | 2,936 | $969K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,108 | 2,973 | $932K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 106,789 | 94,765 | $910K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,291 | 2,204 | $645K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9,876 | 8,050 | $624K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,806 | 1,721 | $596K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 11,339 | 10,542 | $582K |
| 71046 | Radiologic examination, chest; 2 views | 9,531 | 9,209 | $578K |
| 96375 | Therapeutic injection; each additional sequential IV push | 21,976 | 20,455 | $572K |
| 72125 | Computed tomography, cervical spine; without contrast material | 3,244 | 3,114 | $571K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,526 | 1,474 | $522K |
| 96361 | Intravenous infusion, hydration; each additional hour | 16,129 | 15,231 | $501K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,754 | 1,684 | $443K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 549 | 545 | $429K |
| 84443 | Thyroid stimulating hormone (TSH) | 26,756 | 26,094 | $375K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3,513 | 3,360 | $371K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,709 | 2,696 | $367K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 33,687 | 30,702 | $353K |
| 95811 | 510 | 499 | $351K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9,900 | 9,634 | $349K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9,880 | 9,614 | $347K |
| 59025 | Fetal non-stress test | 3,225 | 2,491 | $329K |
| 73562 | 3,867 | 3,652 | $328K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 37,384 | 35,045 | $320K |
| 87070 | 21,006 | 20,472 | $312K | |
| 73610 | 3,251 | 3,130 | $301K | |
| 80061 | Lipid panel | 21,754 | 21,414 | $292K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 9,462 | 9,360 | $281K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 5,337 | 4,975 | $272K |
| 86900 | 11,564 | 10,201 | $251K | |
| 76801 | 2,080 | 1,820 | $250K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 20,334 | 18,041 | $247K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 14,284 | 4,055 | $245K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,182 | 2,124 | $243K |
| 73630 | 3,562 | 3,410 | $241K | |
| 70496 | 924 | 870 | $240K | |
| 70498 | 944 | 885 | $238K | |
| 73030 | 2,966 | 2,800 | $237K | |
| 76830 | Ultrasound, transvaginal | 2,152 | 2,111 | $231K |
| 74018 | 3,430 | 3,331 | $229K | |
| 73130 | 3,346 | 3,148 | $228K | |
| 36415 | Collection of venous blood by venipuncture | 62,423 | 53,422 | $226K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 14,706 | 13,890 | $222K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,687 | 2,966 | $221K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 797 | 784 | $214K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 414 | 403 | $213K |
| 84703 | 21,739 | 20,642 | $207K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,986 | 1,953 | $200K |
| 70486 | 962 | 937 | $195K | |
| 93971 | 1,975 | 1,887 | $192K | |
| 72100 | 2,091 | 2,036 | $188K | |
| 84484 | 19,275 | 14,390 | $172K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,683 | 1,644 | $169K |
| 47562 | 63 | 63 | $168K | |
| 73110 | 2,292 | 2,224 | $159K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 473 | 455 | $157K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8,266 | 7,732 | $157K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 444 | 435 | $154K |
| 93976 | 927 | 909 | $148K | |
| 83690 | 23,933 | 22,359 | $139K | |
| 86780 | 9,605 | 9,426 | $135K | |
| 76641 | 1,175 | 956 | $135K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 16,092 | 15,783 | $132K |
| 93017 | 768 | 752 | $131K | |
| 71250 | 867 | 832 | $124K | |
| 80074 | 2,829 | 2,784 | $124K | |
| 58661 | 40 | 39 | $121K | |
| 93970 | 853 | 829 | $120K | |
| 86850 | 9,903 | 8,857 | $118K | |
| 76775 | 1,046 | 1,009 | $117K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,900 | 1,845 | $113K |
| 81003 | 49,719 | 47,166 | $113K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4,201 | 4,071 | $113K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 250 | 241 | $108K |
| 70491 | 290 | 283 | $106K | |
| 84702 | 6,700 | 5,610 | $106K | |
| 85027 | 17,361 | 15,754 | $104K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 20,365 | 18,640 | $103K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2,704 | 2,692 | $93K |
| 97161 | 2,897 | 2,774 | $91K | |
| 73140 | 1,289 | 1,254 | $90K | |
| 86901 | 11,546 | 10,183 | $89K | |
| 87186 | 6,327 | 6,035 | $85K | |
| 12001 | 840 | 821 | $84K | |
| 83880 | 3,534 | 3,318 | $80K | |
| 87088 | 5,232 | 5,035 | $78K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 3,175 | 2,805 | $78K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3,603 | 1,764 | $77K |
| 87040 | 6,381 | 3,770 | $77K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 6,424 | 5,941 | $77K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,227 | 1,009 | $76K |
| 73080 | 1,164 | 1,127 | $75K | |
| 95806 | 393 | 391 | $74K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 695 | 422 | $74K |
| G0475 | Hiv antigen/antibody, combination assay, screening | 4,348 | 4,287 | $73K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2,476 | 2,414 | $71K |
| 72040 | 844 | 828 | $71K | |
| 88312 | 734 | 714 | $68K | |
| 76536 | 656 | 646 | $67K | |
| 72131 | 322 | 314 | $65K | |
| 73700 | 301 | 284 | $64K | |
| 87420 | 3,573 | 3,486 | $63K | |
| 84439 | 7,664 | 7,514 | $62K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,423 | 1,167 | $61K |
| 83735 | 12,447 | 9,581 | $59K | |
| 82962 | 14,167 | 7,613 | $58K | |
| 85610 | 13,959 | 12,416 | $57K | |
| 73090 | 848 | 812 | $57K | |
| 86803 | 4,568 | 4,517 | $56K | |
| 73590 | 851 | 803 | $55K | |
| 29125 | 383 | 375 | $52K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 433 | 416 | $51K |
| 82607 | 4,147 | 4,088 | $51K | |
| 82728 | 4,433 | 4,346 | $50K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 908 | 447 | $50K |
| 83605 | 6,259 | 5,179 | $49K | |
| 87653 | 1,480 | 1,476 | $48K | |
| 76770 | 524 | 508 | $48K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 123 | 123 | $48K |
| 86696 | 2,359 | 1,551 | $47K | |
| 81001 | 16,670 | 15,769 | $47K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,945 | 1,936 | $47K |
| C1762 | Connective tissue, human (includes fascia lata) | 52 | 52 | $46K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 11,601 | 10,186 | $45K |
| 93458 | 31 | 30 | $44K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,701 | 8,028 | $44K |
| 86762 | 3,697 | 3,571 | $42K | |
| 73502 | 826 | 791 | $41K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 287 | 262 | $41K |
| J2704 | Injection, propofol, 10 mg | 8,956 | 7,597 | $40K |
| 84403 | 1,682 | 1,664 | $40K | |
| 99153 | Mod sedat endo service >5yrs | 703 | 673 | $39K |
| 86787 | 3,540 | 3,492 | $38K | |
| 83013 | 635 | 628 | $37K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 8,416 | 8,068 | $37K |
| J0690 | Injection, cefazolin sodium, 500 mg | 5,087 | 4,562 | $36K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 7,378 | 6,201 | $36K |
| 90715 | 2,394 | 2,339 | $36K | |
| 10060 | 407 | 398 | $35K | |
| 82077 | 2,752 | 2,497 | $35K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 99 | 90 | $34K |
| 87340 | 4,085 | 4,047 | $34K | |
| 86695 | 2,342 | 1,532 | $34K | |
| 82105 | 1,991 | 1,967 | $32K | |
| 31720 | 250 | 243 | $32K | |
| 85379 | 3,840 | 3,690 | $32K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 739 | 713 | $32K |
| 83001 | 1,768 | 1,750 | $31K | |
| H0049 | Alcohol and/or drug screening | 1,488 | 1,419 | $31K |
| 85730 | 6,108 | 5,588 | $31K | |
| 97165 | 1,117 | 1,082 | $30K | |
| 12002 | 282 | 278 | $30K | |
| 73221 | 102 | 98 | $30K | |
| 84146 | 1,588 | 1,572 | $29K | |
| 84402 | 1,220 | 1,207 | $29K | |
| 84481 | 1,921 | 1,891 | $29K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 2,254 | 2,191 | $29K |
| 84145 | 603 | 518 | $28K | |
| 86038 | 2,273 | 2,231 | $27K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 207 | 196 | $27K |
| 76870 | 230 | 224 | $26K | |
| 82746 | 2,208 | 2,174 | $26K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 2,694 | 2,609 | $26K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 254 | 254 | $26K |
| 86140 | 5,023 | 4,727 | $26K | |
| 12011 | 250 | 243 | $25K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 53 | 51 | $25K |
| 94770 | 210 | 193 | $24K | |
| 82570 | 5,700 | 5,298 | $24K | |
| 83002 | 1,347 | 1,334 | $24K | |
| 77080 | 305 | 300 | $23K | |
| 94727 | 248 | 244 | $23K | |
| 83540 | 3,417 | 3,301 | $23K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 6,137 | 5,453 | $23K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 141 | 82 | $23K |
| 82803 | 720 | 547 | $23K | |
| 96376 | 2,008 | 1,911 | $22K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 49 | 49 | $21K |
| 88307 | 108 | 106 | $21K | |
| 72072 | 205 | 198 | $20K | |
| 82670 | 729 | 716 | $20K | |
| 97116 | 1,533 | 1,060 | $20K | |
| 84112 | 529 | 471 | $20K | |
| 87077 | 1,305 | 1,253 | $19K | |
| C1769 | Guide wire | 804 | 759 | $19K |
| 94060 | 202 | 198 | $19K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 2,644 | 2,361 | $19K |
| 80143 | 1,196 | 1,110 | $19K | |
| 99152 | 798 | 754 | $19K | |
| 80179 | 1,180 | 1,101 | $18K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 4,358 | 4,013 | $18K |
| 72141 | 64 | 64 | $17K | |
| 84153 | 1,082 | 1,060 | $16K | |
| 76857 | 204 | 201 | $16K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 251 | 245 | $16K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 36 | 36 | $15K |
| 83525 | 1,356 | 1,343 | $15K | |
| 73560 | 293 | 271 | $15K | |
| 83550 | 2,087 | 2,044 | $15K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 40 | 38 | $15K |
| 84156 | 3,455 | 3,105 | $15K | |
| 82043 | 2,844 | 2,804 | $14K | |
| 82950 | 3,152 | 3,138 | $14K | |
| J2060 | Injection, lorazepam, 2 mg | 2,888 | 2,538 | $14K |
| J2785 | Injection, regadenoson, 0.1 mg | 194 | 188 | $14K |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,600 | 3,057 | $14K |
| 85652 | 5,576 | 5,275 | $14K | |
| 76642 | 173 | 171 | $14K | |
| 82247 | 2,500 | 1,436 | $13K | |
| 82248 | 2,616 | 1,617 | $13K | |
| 84550 | 2,695 | 2,398 | $13K | |
| 71100 | 219 | 214 | $13K | |
| 36591 | 374 | 201 | $12K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,828 | 1,747 | $12K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 55 | 39 | $12K |
| 80050 | General health panel | 789 | 749 | $12K |
| 87081 | 1,679 | 1,644 | $12K | |
| 84480 | 998 | 985 | $12K | |
| 82550 | 2,285 | 1,890 | $11K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,060 | 1,030 | $11K |
| 82627 | 482 | 478 | $11K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,494 | 2,094 | $11K |
| 87210 | 1,583 | 1,518 | $11K | |
| 0002A | 218 | 218 | $10K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 29 | 26 | $10K |
| 95816 | 72 | 70 | $10K | |
| 72170 | 123 | 119 | $10K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 513 | 492 | $10K |
| 86235 | 262 | 139 | $10K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,771 | 2,593 | $9K |
| 83021 | 638 | 634 | $9K | |
| 83615 | 1,754 | 1,435 | $9K | |
| 82150 | 1,815 | 1,770 | $9K | |
| 73660 | 140 | 138 | $9K | |
| 87205 | 2,421 | 2,245 | $9K | |
| 87428 | 162 | 160 | $9K | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 80 | 76 | $9K |
| 84163 | 568 | 565 | $9K | |
| 73552 | 155 | 131 | $9K | |
| 94729 | 249 | 245 | $8K | |
| 84100 | 2,543 | 1,714 | $8K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 72 | 72 | $8K |
| 73060 | 138 | 133 | $8K | |
| 74021 | 105 | 102 | $8K | |
| 87660 | 329 | 326 | $8K | |
| 87480 | 329 | 326 | $8K | |
| 87510 | 329 | 326 | $8K | |
| 72110 | 77 | 77 | $8K | |
| 36430 | 34 | 27 | $7K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 190 | 170 | $7K |
| 85007 | 2,432 | 2,165 | $7K | |
| 86431 | 1,427 | 1,406 | $7K | |
| 80076 | 886 | 871 | $7K | |
| 97162 | 211 | 201 | $7K | |
| 87899 | 201 | 170 | $7K | |
| 82553 | 888 | 717 | $7K | |
| C9113 | Injection, pantoprazole sodium, per vial | 1,637 | 1,303 | $6K |
| C1781 | Mesh (implantable) | 26 | 26 | $6K |
| 86141 | 544 | 533 | $6K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 921 | 883 | $6K |
| 86376 | 410 | 403 | $5K | |
| 87522 | Neg quan hep c or qual rna | 85 | 84 | $5K |
| 73120 | 43 | 39 | $5K | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 83 | 76 | $5K |
| D2929 | 25 | 25 | $5K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,022 | 788 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | 205 | 86 | $4K |
| 76882 | 43 | 41 | $4K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 104 | 38 | $4K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,090 | 967 | $4K |
| 82565 | 1,080 | 1,054 | $4K | |
| 86160 | 345 | 183 | $4K | |
| 82784 | 466 | 436 | $4K | |
| 83970 | 126 | 125 | $4K | |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | 82 | 81 | $4K |
| 87902 | 14 | 14 | $4K | |
| 84425 | 227 | 223 | $4K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 280 | 232 | $4K |
| 82626 | 151 | 151 | $4K | |
| 92523 | 48 | 41 | $4K | |
| 92610 | 66 | 61 | $4K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 581 | 508 | $4K |
| 86225 | 249 | 246 | $3K | |
| 82947 | 868 | 809 | $3K | |
| 70460 | 13 | 13 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 373 | 363 | $3K |
| 83655 | 291 | 286 | $3K | |
| 86003 | 38 | 37 | $3K | |
| 87209 | 141 | 135 | $3K | |
| 87045 | 305 | 294 | $3K | |
| 86200 | 276 | 274 | $3K | |
| 0240U | 146 | 144 | $3K | |
| 74022 | 39 | 38 | $3K | |
| 88342 | 44 | 42 | $3K | |
| 73200 | 13 | 13 | $3K | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 466 | 453 | $3K |
| 86480 | 49 | 48 | $3K | |
| 85018 | 1,279 | 1,151 | $3K | |
| 83498 | 100 | 98 | $3K | |
| 97035 | 169 | 68 | $3K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 648 | 379 | $2K |
| 51702 | 38 | 36 | $2K | |
| 85014 | 1,089 | 1,013 | $2K | |
| 82140 | 246 | 211 | $2K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 321 | 275 | $2K |
| 36592 | 48 | 24 | $2K | |
| 86308 | 337 | 332 | $2K | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 361 | 350 | $2K |
| 93925 | 26 | 25 | $2K | |
| 73620 | 27 | 26 | $2K | |
| 86364 | 176 | 172 | $2K | |
| 86328 | 140 | 137 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 589 | 441 | $2K |
| 96367 | 123 | 120 | $2K | |
| 86800 | 122 | 121 | $2K | |
| 97535 | Self-care/home management training, each 15 minutes | 114 | 101 | $2K |
| 87493 | 50 | 49 | $2K | |
| 87177 | 141 | 135 | $2K | |
| 86592 | 342 | 297 | $2K | |
| 85041 | 628 | 624 | $2K | |
| 82272 | 397 | 378 | $1K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 287 | 263 | $1K |
| J8540 | Dexamethasone, oral, 0.25 mg | 989 | 959 | $1K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 384 | 342 | $1K |
| 84132 | 362 | 286 | $1K | |
| 87075 | 128 | 117 | $1K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 297 | 287 | $1K |
| 84450 | 222 | 219 | $1K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 115 | 112 | $1K |
| 84460 | 205 | 203 | $1K | |
| 74240 | 12 | 12 | $947.55 | |
| 36600 | 99 | 74 | $920.61 | |
| 86255 | 42 | 41 | $918.56 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 308 | 265 | $908.98 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 319 | 306 | $897.19 |
| J3411 | Injection, thiamine hcl, 100 mg | 207 | 177 | $835.87 |
| 72081 | 12 | 12 | $827.20 | |
| J3360 | Injection, diazepam, up to 5 mg | 176 | 168 | $810.01 |
| J1953 | Injection, levetiracetam, 10 mg | 27 | 25 | $789.71 |
| 80164 | 72 | 64 | $708.52 | |
| 88304 | 26 | 26 | $689.07 | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 250 | 222 | $688.77 |
| 84436 | 93 | 91 | $681.98 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 151 | 141 | $680.43 |
| 86706 | 42 | 40 | $664.76 | |
| 82951 | 40 | 40 | $640.68 | |
| 83516 | 64 | 62 | $635.50 | |
| J1630 | Injection, haloperidol, up to 5 mg | 106 | 103 | $579.09 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 206 | 184 | $554.59 |
| 83721 | 62 | 62 | $521.07 | |
| 86665 | 12 | 12 | $469.87 | |
| 82525 | 40 | 39 | $465.09 | |
| 96368 | 85 | 81 | $452.81 | |
| 85045 | 72 | 67 | $427.14 | |
| 84630 | 53 | 52 | $418.01 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 137 | 116 | $387.89 |
| J1956 | Injection, levofloxacin, 250 mg | 121 | 113 | $350.06 |
| J3480 | Injection, potassium chloride, per 2 meq | 114 | 82 | $322.66 |
| G0008 | Administration of influenza virus vaccine | 18 | 17 | $312.20 |
| 84590 | 43 | 42 | $306.42 | |
| 82009 | 71 | 70 | $264.01 | |
| 82533 | 15 | 13 | $263.50 | |
| 84520 | 126 | 117 | $260.32 | |
| 83520 | 12 | 12 | $213.75 | |
| 90686 | 17 | 16 | $212.02 | |
| 86704 | 13 | 13 | $211.80 | |
| 82977 | 28 | 28 | $194.58 | |
| 85049 | 67 | 64 | $193.15 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 802 | 764 | $185.60 |
| 82330 | 16 | 15 | $178.49 | |
| 87338 | 12 | 12 | $168.94 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 13 | 13 | $160.86 |
| 82390 | 14 | 14 | $145.91 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 18 | 18 | $134.35 |
| 80069 | 13 | 12 | $94.98 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 15 | 13 | $76.12 |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 115 | 102 | $75.82 |
| 84295 | 14 | 14 | $59.48 | |
| J0694 | Injection, cefoxitin sodium, 1 gm | 32 | 27 | $55.64 |
| J1790 | Injection, droperidol, up to 5 mg | 13 | 13 | $48.17 |
| G2011 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | 39 | 38 | $47.37 |
| J1940 | Injection, furosemide, up to 20 mg | 23 | 13 | $19.19 |
| J1836 | Injection, metronidazole, 10 mg | 65 | 45 | $6.12 |
| 91300 | 217 | 217 | $0.79 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 131 | 117 | $0.00 |
| G8986 | Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting | 14 | 14 | $0.00 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 106 | 103 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 442 | 411 | $0.00 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 141 | 134 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 364 | 344 | $0.00 |
| 99408 | 14 | 13 | $0.00 |